AACR Recap: Excitement about cancer prevention, new immunotherapies and advocacy
In STAT’s AACR Recap, reporters Matthew Herper and Angus Chen discussed the mood and highlights of one of the world’s largest cancer meetings.
Related Articles
STAT Summit West
Discover the impact of AI and emerging tech on health innovation Register now ABOUT BREAKTHROUGH WEST In Medicine, Artificial Intelligence Gets Real Yes,
Scientists question NIH project’s use of 20th century technology to make a universal flu vaccine
$500 million NIH program to make vaccines against pathogens that can trigger pandemics uses approach pioneered in last century
Scientists question NIH project’s use of 20th century technology to make a universal flu vaccine
$500 million NIH program to make vaccines against pathogens that can trigger pandemics uses approach pioneered in last century
Why it’s still unclear exactly how much banning soda from SNAP could improve health
It’s been an uphill battle to collect data that can prove eliminating the use of SNAP benefits to buy sugary drinks will actually improve health.
Queen Elizabeth Privately Battled Bone Cancer “For a Year or More” Before Her Death
Former British Prime Minister Boris Johnson revealed in his forthcoming memoir, ‘Unleashed,’ that Queen Elizabeth was battling bone cancer for a year or more before…
Justice Department sues Medicare Advantage insurers and brokers, alleging kickbacks
The Justice Department has sued three of the largest Medicare Advantage insurers and three dominant insurance brokerages, alleging a kickbacks scheme.
Scientists question NIH project’s use of 20th century technology to make a universal flu vaccine
$500 million NIH program to make vaccines against pathogens that can trigger pandemics uses approach pioneered in last century
NIH halts funding for new projects with foreign collaborators, citing national security concerns
NIH announced it will no longer allow subawards to foreign institutions, as part of a national security-minded overhaul to how it manages research funding
Scientists question NIH project’s use of 20th century technology to make a universal flu vaccine
$500 million NIH program to make vaccines against pathogens that can trigger pandemics uses approach pioneered in last century